SEGALL BRYANT & HAMILL, LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1006378 CHICAGO, IL

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,155,438

+$702,360 QoQ

Shares Held

240,060

-13.6% QoQ

Ownership

0.075%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#75

of 308 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	498,222	$26,106,832
2	NBIX	Neurocrine Biosciences Inc	64,908	$10,939,594
3	KNSA	Kiniksa Pharmaceuticals International, plc	71,901	$4,598,068
4	AMRX	Amneal Pharmaceuticals, Inc. This page	240,060	$4,155,438
5	LQDA	Liquidia Corp	50,802	$4,050,443
6	ANIP	Ani Pharmaceuticals Inc	32,860	$2,720,150
7	IRWD	Ironwood Pharmaceuticals Inc	408,064	$1,717,949
8	SUPN	Supernus Pharmaceuticals, Inc.	25,931	$1,206,050

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,155,438	240,060	-13.6%	Shares	Sole	2026-08-12
2026-03-31	$3,453,078	277,802	-29.1%	Shares	Sole	2026-05-22
2025-12-31	$4,936,314	391,771	-1.0%	Shares	Sole	2026-02-13
2025-09-30	$3,961,587	395,763	-5.8%	Shares	Sole	2025-11-12
2025-06-30	$3,400,170	420,293	-8.5%	Shares	Sole	2025-08-12
2025-03-31	$3,850,140	459,444	-2.3%	Shares	Sole	2025-05-02
2024-12-31	$3,725,259	470,361	-3.8%	Shares	Sole	2025-02-11
2024-09-30	$4,069,827	489,162	+1.6%	Shares	Sole	2024-11-08
2024-06-30	$3,057,531	481,501	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.